These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8907793

  • 1. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.
    Wahlander H, Sohtell M, Wickman A, Nilsson A, Friberg P.
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):327-34. PubMed ID: 8907793
    [Abstract] [Full Text] [Related]

  • 2. Effects of ACE inhibition and beta-blockade on plasminogen activator inhibitor-1 and transforming growth factor-beta1 in carotid glomus and autonomic ganglia in hypertensive rats.
    Toblli JE, Grana D, Cao G, Milei J.
    Am J Hypertens; 2007 Mar; 20(3):326-34. PubMed ID: 17324747
    [Abstract] [Full Text] [Related]

  • 3. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats.
    Susic D, Varagic J, Frohlich ED.
    J Hypertens; 1999 Aug; 17(8):1209-15. PubMed ID: 10466478
    [Abstract] [Full Text] [Related]

  • 5. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P.
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [Abstract] [Full Text] [Related]

  • 6. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W, Jöhren O, Schwartz S, Gieselberg A, Dominiak P.
    J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
    [Abstract] [Full Text] [Related]

  • 7. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
    Porteri E, Rodella L, Rizzoni D, Rezzani R, Paiardi S, Sleiman I, De Ciuceis C, Boari GE, Castellano M, Bianchi R, Agabiti-Rosei E.
    Blood Press; 2005 Mar; 14(3):184-92. PubMed ID: 16036499
    [Abstract] [Full Text] [Related]

  • 8. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF, de Azevedo Carvalho AC, Pimentel EB, Mill JG, Nascimento JH.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [Abstract] [Full Text] [Related]

  • 9. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
    Dupuis F, Vincent JM, Limiñana P, Chillon JM, Capdeville-Atkinson C, Atkinson J.
    J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
    [Abstract] [Full Text] [Related]

  • 10. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D, Porteri E, Bettoni G, Piccoli A, Castellano M, Muiesan ML, Pasini G, Guelfi D, Rosei EA.
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [Abstract] [Full Text] [Related]

  • 11. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P, Linz W, Schölkens B, Van Even P, Martorana P, Unger T.
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [Abstract] [Full Text] [Related]

  • 12. Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats.
    Rizzoni D, Rodella L, Porteri E, Rezzani R, Sleiman I, Paiardi S, Guelfi D, De Ciuceis C, Boari GE, Bianchi R, Agabiti-Rosei E.
    Clin Exp Hypertens; 2003 Oct; 25(7):427-41. PubMed ID: 14596367
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF.
    Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N, Sugano M, Otsuka S, Hata T.
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [Abstract] [Full Text] [Related]

  • 18. Long-term ACE inhibition doubles lifespan of hypertensive rats.
    Linz W, Jessen T, Becker RH, Schölkens BA, Wiemer G.
    Circulation; 1997 Nov 04; 96(9):3164-72. PubMed ID: 9386189
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin-converting enzyme inhibitory peptide LAP on vascular remodeling.
    Huang J, Luo M, Fang H, Zheng H, Shen Y, Li L, Deng Y, Xu H.
    Clin Exp Hypertens; 2013 Nov 04; 35(6):437-43. PubMed ID: 23198680
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats.
    Dupuis F, Atkinson J, Limiñana P, Chillon JM.
    J Hypertens; 2005 May 04; 23(5):1061-6. PubMed ID: 15834293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.